Month

Year

Posts:

Fund manager

Funds:

Laurie Don

Cannabinoid approval supports GW’s strategy

With GPs now able to prescribe two cannabis-based medicines from GW Pharmaceuticals, Laurie Don runs the rule over this long-term holding in the Liontrust SF Funds. Read more
Laurie Don

Alzheimer's: new research provides big opportunities

Laurie Don, Investment Manager at ATI, discusses the potential investment opportunities in companies trialling new treatments for Alzheimer’s disease. Read more